Healthcare expenditure and its predictors in a cohort of Australians living with sciatica.
Alexander ChyeChung-Wei Christine LinMark J HancockIan A HarrisJane LatimerChristopher G MaherAndrew J McLachlanStephanie MathiesonBart W KoesRichard Osborne DayLaurent BillotStephen JanBlake J AngellPublished in: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2020)
Our results suggest inefficiency in the use of healthcare resources due to increased healthcare resource utilisation in people with sciatica treated with pregabalin, compared to placebo. Costs of treating sciatica varied based on individual quality of life and socio-economic characteristics.